ArticleStatistics in biopharmaceutical research2025

Comb-BOIN12: A Utility-Based Bayesian Optimal Interval Design for Dose Optimization in Cancer Drug-Combination Trials.

Mengyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.